Adult Extracorporeal Membrane Oxygenator Market Trends and Forecast
The future of the global adult extracorporeal membrane oxygenator market looks promising with opportunities in the cardiovascular surgery and extracorporeal circulation markets. The global adult extracorporeal membrane oxygenator market is expected to grow with a CAGR of 5% from 2025 to 2031. The major drivers for this market are the rising incidence of respiratory & cardiac diseases, the growing awareness & advancements in healthcare technologies, and the increasing availability of healthcare funding & support.
• Lucintel forecasts that, within the type category, polypropylene is expected to witness the highest growth over the forecast period.
• Within the application category, cardiovascular surgery is expected to witness higher growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the Adult Extracorporeal Membrane Oxygenator Market
The adult extracorporeal membrane oxygenator industry is being influenced by several major trends that are defining its future direction. These trends are being fueled by the demand for more efficient, affordable, and patient-focused approaches to critical cardiopulmonary support. Advancements in technology, changing clinical practices, and a better realization of adult extracorporeal membrane oxygenator ÄX%$%Xs potential in different applications are driving these developments. These trends are focused on enhancing patient outcomes, broadening the use of adult extracorporeal membrane oxygenator therapy, and making the best use of healthcare system resources.
• Portability and Miniaturization: Classic adult extracorporeal membrane oxygenator systems tended to be cumbersome and limiting patient mobility. Current innovations involve the creation of smaller, integrated, and transportable adult extracorporeal membrane oxygenator devices. This enables more convenient transportation of patients between and within healthcare institutions without compromising life support. Portable adult extracorporeal membrane oxygenator systems may also facilitate use of adult extracorporeal membrane oxygenator in smaller hospitals and emergency facilities, possibly broadening access to this life-saving treatment for a wider patient base.
• Technology Development in Biocompatible Materials & Oxygenator: Creation of new biocompatible materials for the use in adult extracorporeal membrane oxygenator circuits such as oxygenators and tubes is essential in preventing complications like hemolysis and blood clots. Improvement of gas exchange performance and a less frequent replacement in oxygenators design is achieved with technology advancement. These innovations result in improved and safer adult extracorporeal membrane oxygenator support, which can lead to better patient outcomes and a lower cost of therapy overall by reducing complications and the requirement for further interventions.
• Increasing Use of Venom-Venous Adult (ECMO) for Respiratory Failure: VV-adult extracorporeal membrane oxygenator is being increasingly used as a first-line support option for critically ill patients with severe respiratory failure, including Acute Respiratory Distress Syndrome (ARDS) and pneumonia caused by influenza. Improvements in patient selection and VV-adult extracorporeal membrane oxygenator management protocols have shown increased survival in certain patient groups. This is an indication of increased appreciation of the utility of VV-adult extracorporeal membrane oxygenator in supporting the lungs with preservation of native cardiac function, which can ultimately be more favorable than using conventional mechanical ventilation alone in some instances.
• Integration of Remote Monitoring & Digital Health Technologies: Integration of digital health technologies like data analytics and remote monitoring systems is a growing trend in the management of adult extracorporeal membrane oxygenator . Ongoing monitoring of patient responses, adult extracorporeal membrane oxygenator circuit parameters, and vital signs can facilitate earlier detection of complications and timely intervention. Data analysis and artificial intelligence (AI) can also help optimize adult extracorporeal membrane oxygenator settings and predict patient outcome, potentially making more customized and effective adult extracorporeal membrane oxygenator therapy possible.
• Expansion of Adult (ECMO) Use into Non-Traditional ICU Environments: Although adult extracorporeal membrane oxygenator has long been applied within intensive care units, its use is expanding into non-traditional environments, including cardiac catheterization suites for high-risk intervention and as a bridge to transplantation of the lung or heart. There is increased interest in adult extracorporeal membrane oxygenator being utilized in extracorporeal cardiopulmonary resuscitation (ECPR) in cases of cardiac arrest. Investigating and extending these uses might be able to enhance survival rates and outcomes for more critically ill patients who could benefit from temporary cardiopulmonary support.
These trends together are transforming the adult extracorporeal membrane oxygenator market collectively through innovation, enhancing patient care, and increasing access to this lifesaving therapy. The emphasis on portability, biocompatibility, digitalization, and expanding applications is aimed at making adult extracorporeal membrane oxygenator more widely available, safer, and more effective in the treatment of extreme cardiopulmonary failure among adults.
Recent Development in the Adult Extracorporeal Membrane Oxygenator Market
The mature adult extracorporeal membrane oxygenator market is marked by ongoing developments to enhance the outcomes of patients and broaden the applications of this life-supporting therapy. New developments range from technologies, clinical practice developments, to strategic business activities. They all exhibit a dedication to making adult extracorporeal membrane oxygenator safer, more effective, and more accessible for more patients with critical cardiopulmonary diseases.
• More Integrated and Compact adult extracorporeal membrane oxygenator Systems: Manufacturers are now more interested in creating adult extracorporeal membrane oxygenator systems that are more compact, easier to use, and integrate different components to make setup and management easier. For example, Getinge introduced the Rota flow II extracorporeal life support system, which, when used with the Permanent Life Support (PLS) Set, provides cardiopulmonary support for up to 14 days in a portable and dependable way. This trend improves ease of use and provides more patient mobility during adult extracorporeal membrane oxygenator treatment.
• Development of Oxygenator Design and Biocompatibility: Considerable advancement has been made in the development of oxygenators with better gas exchange efficiency and improved biocompatibility. Innovations like coated hollow fiber membranes have been designed to minimize blood-material interactions, reducing complications such as thrombosis and hemolysis. These developments result in safer and longer adult extracorporeal membrane oxygenator support, possibly translating into improved patient outcomes and lower healthcare costs for complications.
• Refinement of Cannulation Techniques and Strategies: Clinical research and experience are resulting in refining cannulation techniques to maximize blood flow and avoid complications. For instance, employment of double-lumen catheters for VV-adult extracorporeal membrane oxygenator and dedicated cannula in particular patient subgroups are evolving. Enhanced cannulation strategies target delivering sufficient circulatory support without increasing the risk of bleeding, infection, or vascular injury and thus improving the safety of the patient during adult extracorporeal membrane oxygenator .
• Escalating Use of adult extracorporeal membrane oxygenator in Extracorporeal Cardiopulmonary Resuscitation (ECPR): Growing interest and uptake of adult extracorporeal membrane oxygenator for ECPR among patients presenting with cardiac arrest, especially after the failure of conventional CPR. Research and clinical guidelines are under development to specify the best application of ECPR, including the selection criteria of patients and mode of implementation. This advance presents a possible lifeline for patients with refractory cardiac arrest, seeking to enhance survival rates and neurological status.
• Integration of Advanced Monitoring and Management Protocols: Integration of advanced monitoring technologies and standardized management protocols is increasingly common in adult extracorporeal membrane oxygenator centers. These involve ongoing monitoring of hemodynamic parameters, oxygenation, and adult extracorporeal membrane oxygenator circuit function. Standardized anticoagulation, infection control, and weaning from adult extracorporeal membrane oxygenator protocols are intended to enhance consistency of care and minimize variability of patient outcomes between centers.
These new developments are having a significant effect on the adult extracorporeal membrane oxygenator market by making the technology more accessible, safer, and efficient. The emphasis on compact systems, better biocompatibility, improved techniques, greater applications such as ECPR, and standardized protocols is leading to improved patient outcomes and wider adoption of adult extracorporeal membrane oxygenator in critical care.
Strategic Growth Opportunities in the Adult Extracorporeal Membrane Oxygenator Market
The adult extracorporeal membrane oxygenator market offers various strategic growth opportunities across different clinical applications. As the technology and understanding of adult extracorporeal membrane oxygenator improve, its application in the treatment of a broader array of critical conditions is increasing. These opportunities can be identified and leveraged to drive market growth and enhance the outcomes for critically ill patients with severe cardiopulmonary failure.
• Increased Use in Severe Acute Respiratory Distress Syndrome (ARDS): ARDS continues to be a major indication for adult extracorporeal membrane oxygenator , and there remains the possibility of further increasing patient selection criteria and further improving adult extracorporeal membrane oxygenator management strategies to enhance the outcome in this difficult syndrome. As greater recognition of the advantage of adult extracorporeal membrane oxygenator in certain ARDS subgroups, for example, patients with refractory hypoxemia or hypercapnia, occurs, focused use can result in improved survival and decreased ventilator-induced lung injury.
• Expanded Use in Cardiogenic Shock: adult extracorporeal membrane oxygenator is being used more to augment patients with severe cardiogenic shock as a bridge to recovery, bridge to decision (e.g., transplant or mechanical circulatory support device), or bridge to destination therapy. With expanding evidence of the utility of adult extracorporeal membrane oxygenator in achieving hemodynamic stability and end-organ perfusion in cardiogenic shock, there exists the possibility of expanded use and incorporation into typical treatment guidelines for this severe illness.
• Increasing Role in Extracorporeal Cardiopulmonary Resuscitation (ECPR): ECPR is a major growth area, especially in enhancing outcomes for patients with in-hospital or out-of-hospital cardiac arrest who are unresponsive to standard resuscitation. Creating standardized protocols, educating healthcare professionals in ECPR, and implementing effective systems for rapid adult extracorporeal membrane oxygenator deployment can improve survival rates and neurological outcomes in this difficult patient group.
• Use as a Bridge to Lung Transplantation: adult extracorporeal membrane oxygenator is an important role in supporting end-stage lung disease patients who are waiting for transplantation. Maximizing the use of adult extracorporeal membrane oxygenator as a bridge to transplant, including patient management on long-term adult extracorporeal membrane oxygenator support and avoiding complications, is an important area of growth. Improvements in portable adult extracorporeal membrane oxygenator systems may also allow more mobility for transplant candidates, which could potentially improve their overall status at the time of surgery.
• Support for High-Risk Cardiac Intervention: adult extracorporeal membrane oxygenator can play a critical role in supporting high-risk cardiac procedures, including percutaneous coronary intervention (PCI) in patients with acute severe left ventricular failure or for complex electrophysiological procedures. Prophylactic or rescue adult extracorporeal membrane oxygenator in these cases can stabilize hemodynamics and enhance patient safety, potentially increasing the feasibility of advanced cardiac procedures in high-risk patients.
These strategic opportunities for growth emphasize the promise that adult extracorporeal membrane oxygenator holds in meeting important unmet needs in treatment of severe cardiopulmonary failure in a variety of clinical settings. Through commitment to research, education, and infrastructure and protocol development, the adult extracorporeal membrane oxygenator market can grow and continue to enhance outcomes for critically ill patients.
Adult Extracorporeal Membrane Oxygenator Market Driver and Challenges
The adult extracorporeal membrane oxygenator market is driven by a multifaceted interplay of drivers and challenges that influence its growth and adoption. These include technological innovation, economic factors, regulatory environments, and clinical practices. It is important to understand these dynamics for stakeholders to effectively navigate the market and leverage opportunities while avoiding potential risks.
The factors responsible for driving the adult extracorporeal membrane oxygenator market include:
1. Rise in Incidence of Cardiopulmonary Disorders: The increasing number of severe respiratory and cardiac diseases, including ARDS, COPD, heart failure, and cardiogenic shock, is a major impetus for the adult extracorporeal membrane oxygenator market. Aging populations, lifestyle disorders, and global pandemics are among the factors that ensure a greater number of patients who need sophisticated life support, including adult extracorporeal membrane oxygenator , to enhance survival and recovery.
2. Technological Developments in adult extracorporeal membrane oxygenator Equipment: Ongoing development in adult extracorporeal membrane oxygenator technology, such as more portable, user-friendly, and efficient systems, is a key driver. Advances in oxygenator design, biocompatible materials, and embedded monitoring features increase the safety and effectiveness of adult extracorporeal membrane oxygenator , which makes it an increasingly viable solution for more patients and clinical situations.
3. Evolving Awareness and Utilization of adult extracorporeal membrane oxygenator in Critical Care: Evolving awareness among clinicians regarding the value of adult extracorporeal membrane oxygenator in the management of acute cardiopulmonary failure is propelling its utilization in critical care. Publication of clinical reports showing better outcomes in certain patient populations and transfer of knowledge through conferences and educational programs are the drivers of this increased acceptance.
4. Growth of adult extracorporeal membrane oxygenator Centers and Infrastructure: The growth of more adult extracorporeal membrane oxygenator centers with specialized staff and infrastructure is essential for enhancing the availability of this therapy. Investments in critical care units and creation of regional adult extracorporeal membrane oxygenator networks ensure prompt patient transfer and care for patients eligible for adult extracorporeal membrane oxygenator support, thus driving growth in the market.
5. Encouraging Reimbursement Policies in Developed Economies: Favorable reimbursement policies in a majority of developed economies encourage adult extracorporeal membrane oxygenator procedures and related services, thus lowering the costs for hospitals and patients alike and encouraging hospitals to adopt adult extracorporeal membrane oxygenator as a standard of care for candidates. Encouraging healthcare policies, which acknowledge the efficacy of adult extracorporeal membrane oxygenator in improving outcomes, are a main factor in driving market growth.
Challenges in the adult extracorporeal membrane oxygenator market are:
1. Expensive adult extracorporeal membrane oxygenator Therapy: The expense of adult extracorporeal membrane oxygenator systems, disposable supplies, and the fact that a very specialized medical team is required may be a main obstacle to broader adoption, especially in resource-scarce settings. The overall cost of adult extracorporeal membrane oxygenator therapy, including extended lengths of stay and possible complications, is a challenge for healthcare systems and payers.
2. Need for Well-Trained Specialist Personnel: It is only feasible to successfully initiate and operate adult extracorporeal membrane oxygenator through an inter-disciplinary team of appropriately trained physicians, nurses, perfusionists, and respiratory therapists. A deficit in appropriately trained personnel may circumscribe provision of adult extracorporeal membrane oxygenator services and form a hurdle toward scaling up adult extracorporeal membrane oxygenator programs, particularly in places with weaker infrastructure of healthcare resources.
3. Risk of Complications and Adverse Events: In spite of technological and clinical advances, adult extracorporeal membrane oxygenator therapy carries the risk of complications including bleeding, thrombosis, infection, and neurological events. These complications are managed by meticulous monitoring and specialist expertise, and the risk of adverse events may affect the decision to start and maintain adult extracorporeal membrane oxygenator support.
In short, the adult extracorporeal membrane oxygenator market is driven by the growing demand for advanced cardiovascular support as a result of the growing burden of severe cardiopulmonary conditions and by continuous technology improvements that provide greater safety and effectiveness in adult extracorporeal membrane oxygenator devices. Nonetheless, factors that might impede its wider use include the expense of therapy, the requirement for technical expertise, and complications risks. Meeting these challenges with cost-effective solutions, improved training programs, and measures to reduce adverse events will be key to the future growth and expansion of the adult extracorporeal membrane oxygenator market.
List of Adult Extracorporeal Membrane Oxygenator Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adult extracorporeal membrane oxygenator companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adult extracorporeal membrane oxygenator companies profiled in this report include-
• NIPRO
• Terumo
• Eurosets
• Getinge
• Cardio Help Bangladesh
• LivaNova
• Medos
• Baxter
• Medcomp
• Medtronic
Adult Extracorporeal Membrane Oxygenator Market by Segment
The study includes a forecast for the global adult extracorporeal membrane oxygenator market by type, application, and region.
Adult Extracorporeal Membrane Oxygenator Market by Type [Value from 2019 to 2031]:
• Polypropylene
• Polymethylpentene
• Silicone
Adult Extracorporeal Membrane Oxygenator Market by Application [Value from 2019 to 2031]:
• Cardiovascular Surgery
• Extracorporeal Circulation
• Others
Adult Extracorporeal Membrane Oxygenator Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Adult Extracorporeal Membrane Oxygenator Market
The market for the adult extracorporeal membrane oxygenator continues to grow due to rising incidence of cardiopulmonary disorders and technological improvements. adult extracorporeal membrane oxygenator delivers vital life support to patients with critical heart and lung failure, serving as a man-made heart and lung to oxygenate blood outside the human body. Recent advances throughout major regions reflect a worldwide trend toward improving adult extracorporeal membrane oxygenator technology, availability, and patient outcomes. This encompasses creation of more efficient and portable machines, enhanced material biocompatibility, and mounting use in diverse clinical environments other than conventional intensive care units.
• United States: The US adult extracorporeal membrane oxygenator service market is growing, with a projected value of $71.18 million by 2028 compared to a 2020 value of $47.93 million, with an expected CAGR of 5.81%. The growth is driven by an increasing geriatric population and growing cases of coronary heart disease. Recent developments are the creation of miniaturized, transportable adult extracorporeal membrane oxygenator machines that are ideal for use in emergency cases and less complicated patient transport, which is the biggest service type segment. The respiratory application is the biggest market segment due to increasing cardiovascular and respiratory illnesses and the bridge-to-lung-transplantation use of adult extracorporeal membrane oxygenator .
• China: ChinaÄX%$%Xs adult extracorporeal membrane oxygenator cannula market will reach $2.4 million in 2030 at a CAGR of 5.5% from 2024. Venom-arterial cannulation is the fastest-growing and largest segment. A new, locally designed adult extracorporeal membrane oxygenator system, the Henri Hong yuan (HR-adult extracorporeal membrane oxygenator ), has had initial evaluations. China held 5.0% of the worldwide adult extracorporeal membrane oxygenator cannula market share in 2023 and is expected to dominate the Asia Pacific region in revenue by 2030. The growth is due to rising use of advanced life support technologies within Chinese healthcare.
• Germany: GermanyÄX%$%Xs adult extracorporeal membrane oxygenator cannula market is expected to hit $2.0 million by 2030, growing at a CAGR of 4.4% from 2024. Like China, the venom-arterial segment is the largest and most rapidly growing. Germany held 4.5% of the global adult extracorporeal membrane oxygenator cannula market share in 2023 and is forecast to dominate Europe in revenue terms by 2030. The growth of the European adult extracorporeal membrane oxygenator market is associated with a greater prevalence of respiratory and cardiovascular diseases, as well as substantial investment in advanced life support equipment within GermanyÄX%$%Xs well-established medical infrastructure.
• India: The Indian market for adult extracorporeal membrane oxygenator machines is anticipated to grow to $15.1 million in 2030, at a CAGR of 6.6% between 2024 and 2030. The largest and most rapidly growing component segment is oxygenators. India had a 3.1% share of the worldÄX%$%Xs adult extracorporeal membrane oxygenator machine market in 2023. The growth of the market is driven by rising healthcare expenditure and rising chronic disease incidence, with a significant rise in cardiovascular disease incidence. Increasing investments in critical care centers and growing adult extracorporeal membrane oxygenator programs also fuel this fast growth.
• Japan: The Japanese market for adult extracorporeal membrane oxygenator machines reached $33.1 million in 2024 and is expected to reach $50.1 million by 2033, growing at a CAGR of 4.7% from 2025-2033. This growth is fueled by the rising incidence of respiratory and cardiac diseases and improvements in adult extracorporeal membrane oxygenator technology, such as more portable and easy-to-use devices. Both the aging population and the increasing awareness of adult extracorporeal membrane oxygenator as a life-saving procedure are also contributing factors. Continuous research and development activities are now driving better features and functionality of adult extracorporeal membrane oxygenator machines in Japan.
Features of the Global Adult Extracorporeal Membrane Oxygenator Market
Market Size Estimates: Adult extracorporeal membrane oxygenator market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Adult extracorporeal membrane oxygenator market size by type, application, and region in terms of value ($B).
Regional Analysis: Adult extracorporeal membrane oxygenator market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the adult extracorporeal membrane oxygenator market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adult extracorporeal membrane oxygenator market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for adult extracorporeal membrane oxygenator market?
Answer: The global adult extracorporeal membrane oxygenator market is expected to grow with a CAGR of 5% from 2025 to 2031.
Q2. What are the major drivers influencing the growth of the adult extracorporeal membrane oxygenator market?
Answer: The major drivers for this market are the rising incidence of respiratory & cardiac diseases, the growing awareness & advancements in healthcare technologies, and the increasing availability of healthcare funding & support.
Q3. What are the major segments for adult extracorporeal membrane oxygenator market?
Answer: The future of the adult extracorporeal membrane oxygenator market looks promising with opportunities in the cardiovascular surgery and extracorporeal circulation markets.
Q4. Who are the key adult extracorporeal membrane oxygenator market companies?
Answer: Some of the key adult extracorporeal membrane oxygenator companies are as follows:
• NIPRO
• Terumo
• Eurosets
• Getinge
• Cardio Help Bangladesh
• LivaNova
• Medos
• Baxter
• Medcomp
• Medtronic
Q5. Which adult extracorporeal membrane oxygenator market segment will be the largest in future?
Answer: Lucintel forecasts that, within the type category, polypropylene is expected to witness the highest growth over the forecast period.
Q6. In adult extracorporeal membrane oxygenator market, which region is expected to be the largest in next 5 years?
Answer: In terms of region, North America is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the adult extracorporeal membrane oxygenator market by type (polypropylene, polymethylpentene, and silicone), application (cardiovascular surgery, extracorporeal circulation, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Adult Extracorporeal Membrane Oxygenator Market, Adult Extracorporeal Membrane Oxygenator Market Size, Adult Extracorporeal Membrane Oxygenator Market Growth, Adult Extracorporeal Membrane Oxygenator Market Analysis, Adult Extracorporeal Membrane Oxygenator Market Report, Adult Extracorporeal Membrane Oxygenator Market Share, Adult Extracorporeal Membrane Oxygenator Market Trends, Adult Extracorporeal Membrane Oxygenator Market Forecast, Adult Extracorporeal Membrane Oxygenator Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.